Advertisement
Table 3 Baseline data available from patients who were allocated to the study (intervention = 1034, control = 501)
| Type 2 Diabetes | Coronary artery disease | Congestive heart failure | ||||
|---|---|---|---|---|---|---|
| Intervention | Control | Intervention | Control | Intervention | Control | |
| Number of patients | 770 | 359 | 172 | 97 | 92 | 45 |
| Age (years) | 64.6 (9.4) | 65.6 (9.5) | 65.4 (9.4) | 66.0 (8.6) | 67.3 (7.9) | 62.4 (7.7) |
| Sex (% male) | 58.3 | 54.0 | 69.2 | 73.2 | 65.2 | 64.4 |
| Age at self reported year of diagnosis | 54.3 (11.1) | 56.1 (11.8) | 60.8 (10.2) | 61.3 (10.1) | 63.9 (7.9) | 56.8 (9.3) |
| 311 | 145 | 121 | 69 | 51 | 25 | |
| Self-reported duration of disease | 10.3 (8.4) | 9.2 (8.2) | 4.7 (6.6) | 4.8 (7.6) | 4.4 (5.4) | 4.2 (3.7) |
| 302 | 142 | 120 | 68 | 51 | 25 | |
| Body mass index | 32.3 (6.2) | 31.9 (5.7) | 28.3 (4.1) | 28.8 (5.1) | 30.2 (6.6) | 29.9 (6.9) |
| 727 | 338 | 164 | 91 | 81 | 42 | |
| Waist circumference (M/F) | 109.9 (14.4)/ 106.8 (15.5) | 110.1 (12.8)/ 104.8 (15.1) | 100.3 (11.0)/ 95.1 (12.8) | 102.9 (11.7)/ 91.5 (12.6) | 106.7 (12.8)/ 94.1 (14.6) | 108.0 (17.9)/ 89.6 (17.3) |
| 429/298 | 182/156 | 116/47 | 66/25 | 55/25 | 25/16 | |
| Systolic blood pressure (mmHg) | 143.4 (20.0) | 143.1 (20.2) | 137.6 (20.5) | 139.9 (18.2) | 132.9 (23.7) | 127.6 (22.7) |
| 727 | 337 | 163 | 91 | 81 | 42 | |
| Diastolic blood pressure (mmHg) | 84.2 (11.1) | 84.1 (10.8) | 81.0 (12.2) | 82.1 (10.5) | 81.3 (14.1) | 80.2 (11.5) |
| 727 | 338 | 163 | 91 | 81 | 42 | |
| Serum total cholesterol (mmol/l) | 4.4 (1.1) | 4.4 (0.9) | 3.8 (0.9) | 3.8 (1.0) | 4.0 (1.2) | 4.0 (1.4) |
| 225 | 121 | 66 | 46 | 23 | 12 | |
| Serum HDL cholesterol (mmol/l) | 1.2 (0.4) | 1.3 (0.4) | 1.4 (0.4) | 1.3 (0.4) | 1.1 (0.4) | 1.3 (0.5) |
| 219 | 119 | 65 | 45 | 23 | 11 | |
| Serum LDL cholesterol (mmol/l) | 2.3 (0.8) | 2.4 (0.8) | 1.9 (0.6) | 1.9 (0.7) | 2.1 (0.9) | 2.2 (0.9) |
| 210 | 115 | 65 | 45 | 21 | 11 | |
| Lipid lowering medication (%) | 24.7 | 20.3 | 60.5 | 55.7 | 38.0 | 22.2 |
| 190 | 73 | 104 | 54 | 35 | 10 | |
| Daily smokers (%) | 12.7 | 11.0 | 11.9 | 10.1 | 12.7 | 12.2 |
| 88/691 | 36/327 | 19/160 | 9/89 | 10/79 | 5/41 | |
| Hb1Ac (%) | 7.5 (1.1) | 7.7 (1.7) | ||||
| 415 | 224 | |||||
| Oral antidiabetic drug and insulin (%) | 12.3 | 13.1 | ||||
| 95 | 47 | |||||
| Oral antidiabetic drug (%) | 34.0 | 29.8 | ||||
| 262 | 107 | |||||
| Insulin (%) | 16.8 | 16.7 | ||||
| 129 | 60 | |||||
| SCORE1 | 8.0 (6.3) | 7.6 (7.9) | ||||
| 215 | 115 | |||||
| NYHA2 | 2.4 (1.4) | 2.5 (1.4) | ||||
| 52 | 30 | |||||
